[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
April 25, 2007

Clopidogrel and Long-term Outcomes After Drug-Eluting Stent Implantation

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2007;297(16):1769-1771. doi:10.1001/jama.297.16.1770-a

To the Editor: In studying the appropriate duration of dual antiplatelet therapy in patients with DES, Dr Eisenstein and colleagues1 report the results obtained from the analysis of a large registry of patients who underwent intracoronary stents. They found that in patients with DES, extended use of clopidogrel with aspirin appears to be associated with a reduction in rates of death, as well as the composite outcome of death or myocardial infarction. While these results provide value while waiting for an eventual randomized clinical trial, they would be more interpretable with additional information.

First Page Preview View Large
First page PDF preview
First page PDF preview
×